Physical inactivity and protein energy wasting play independent roles in muscle weakness in maintenance haemodialysis patients

Jean-Sébastien Souweine, Nils Kuster, Leila Chenine, Annie Rodriguez, Laure Patrier, Marion Morena, Eric Badia, Lotfi Chalabi, Nathalie Raynal, Isabelle Ohresser, Helene Leray-Moragues, Jacques Mercier, Maurice Hayot, Moglie Le Quintrec, Fares Gouzi, Jean-Paul Cristol, Jean-Sébastien Souweine, Nils Kuster, Leila Chenine, Annie Rodriguez, Laure Patrier, Marion Morena, Eric Badia, Lotfi Chalabi, Nathalie Raynal, Isabelle Ohresser, Helene Leray-Moragues, Jacques Mercier, Maurice Hayot, Moglie Le Quintrec, Fares Gouzi, Jean-Paul Cristol

Abstract

Background: Muscle weakness is associated with increased mortality risk in chronic haemodialysis (CHD) patients. Protein energy wasting (PEW) and low physical activity could impair muscle quality and contribute to muscle weakness beyond muscle wasting in these patients. Aim of this study was to assess clinical and biological parameters involved in the reduction of muscle strength of CHD patients.

Methods: One hundred and twenty-three CHD patients (80 males, 43 females; 68,8 [57.9-78.8] y.o.) were included in this study. Maximal voluntary force (MVF) of quadriceps was assessed using a belt-stabilized hand-held dynamometer. Muscle quality was evaluated by muscle specific torque, defined as the strength per unit of muscle mass. Muscle mass was estimated using lean tissue index (LTI), skeletal muscle mass (SMM) assessed by bioelectrical impedance analysis and creatinine index (CI). Voorrips questionnaire was used to estimate physical activity. Criteria for the diagnosis of PEW were serum albumin, body mass index < 23 kg/m2, creatinine index < 18.82 mg/kg/d and low dietary protein intake estimated by nPCR < 0.80g/kg/d.

Results: MVF was 76.1 [58.2-111.7] N.m. and was associated with CI (β = 5.3 [2.2-8.4], p = 0.001), LTI (β = 2.8 [0.6-5.1], p = 0.013), Voorrips score (β = 17.4 [2.9-31.9], p = 0.02) and serum albumin (β = 1.9 [0.5-3.2], p = 0.006). Only serum albumin (β = 0.09 [0.03-0.15], p = 0.003), Voorrips score (β = 0.8 [0.2-1.5], p = 0.005) and CI (β = 0.2 [0.1-0.3], p<0.001) remained associated with muscle specific torque. Thirty patients have dynapenia defined as impaired MVF with maintained SMM and were younger with high hs-CRP (p = 0.001), PEW criteria (p<0.001) and low Voorrips score (p = 0.001), and reduced dialysis vintage (p<0.046).

Conclusions: Beyond atrophy, physical inactivity and PEW conspire to impair muscle strength and specific torque in CHD patients and could be related to muscle quality.

Trial registration: ClinicalTrials.gov NCT02806089.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Flow chart diagram depicting number…
Fig 1. Flow chart diagram depicting number of patients evaluated for eligibility and number of patients included in analysis.
Fig 2. Correlation between observed maximal voluntary…
Fig 2. Correlation between observed maximal voluntary force (N.m) and theoretical maximal voluntary force (N.m).
Red line represents the line of identity.
Fig 3. Spearman’s partial correlation.
Fig 3. Spearman’s partial correlation.
The correlation network shows partial correlations of maximal voluntary force, muscle mass, nutritional markers and dialysis dose.
Fig 4. Quantile distribution between maximal voluntary…
Fig 4. Quantile distribution between maximal voluntary force and skeletal muscle mass.
Dynapenia was defined as the lowest quartile.

References

    1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39: 412–423. 10.1093/ageing/afq034
    1. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73: 391–398. 10.1038/sj.ki.5002585
    1. Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Bàràny P, Heimbürger O, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol CJASN. 2014;9: 1720–1728. 10.2215/CJN.10261013
    1. Kittiskulnam P, Carrero JJ, Chertow GM, Kaysen GA, Delgado C, Johansen KL. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle. 2017;8: 57–68. 10.1002/jcsm.12130
    1. Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc—Eur Ren Assoc. 2015;30: 1718–1725. 10.1093/ndt/gfv133
    1. Chandler JM, Duncan PW, Kochersberger G, Studenski S. Is lower extremity strength gain associated with improvement in physical performance and disability in frail, community-dwelling elders? Arch Phys Med Rehabil. 1998;79: 24–30.
    1. Pedruzzi LM, Stockler-Pinto MB, Leite M Jr, Mafra D. Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease? Biochimie. 2012;94: 2461–2466. 10.1016/j.biochi.2012.07.015
    1. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc—Eur Ren Assoc. 2000;15: 953–960.
    1. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found. 2013;23: 77–90. 10.1053/j.jrn.2013.01.001
    1. Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K. Latest consensus and update on protein-energy wasting in chronic kidney disease: Curr Opin Clin Nutr Metab Care. 2015;18: 254–262. 10.1097/MCO.0000000000000171
    1. Domański M, Ciechanowski K. Sarcopenia: a major challenge in elderly patients with end-stage renal disease. J Aging Res. 2012;2012: 754739 10.1155/2012/754739
    1. Francis P, Toomey C, Mc Cormack W, Lyons M, Jakeman P. Measurement of maximal isometric torque and muscle quality of the knee extensors and flexors in healthy 50- to 70-year-old women. Clin Physiol Funct Imaging. 2016; 10.1111/cpf.12332
    1. Souweine J-S, Boudet A, Chenine L, Leray H, Rodriguez A, Mourad G, et al. Standardized Method to Measure Muscle Force at the Bedside in Hemodialysis Patients. J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found. 2017; 10.1053/j.jrn.2017.01.017
    1. Clark BC, Manini TM. Sarcopenia = / = dynapenia. J Gerontol A Biol Sci Med Sci. 2008;63: 829–834.
    1. Clark BC, Manini TM. What is dynapenia? Nutr Burbank Los Angel Cty Calif. 2012;28: 495–503. 10.1016/j.nut.2011.12.002
    1. Raj DSC, Boivin MA, Dominic EA, Boyd A, Roy PK, Rihani T, et al. Haemodialysis induces mitochondrial dysfunction and apoptosis. Eur J Clin Invest. 2007;37: 971–977. 10.1111/j.1365-2362.2007.01886.x
    1. Gamboa JL, Billings FT, Bojanowski MT, Gilliam LA, Yu C, Roshanravan B, et al. Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease. Physiol Rep. 2016;4: e12780 10.14814/phy2.12780
    1. Adey D, Kumar R, McCarthy JT, Nair KS. Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol Endocrinol Metab. 2000;278: E219–225. 10.1152/ajpendo.2000.278.2.E219
    1. Canaud B, Granger Vallée A, Molinari N, Chenine L, Leray-Moragues H, Rodriguez A, et al. Creatinine index as a surrogate of lean body mass derived from urea Kt/V, pre-dialysis serum levels and anthropometric characteristics of haemodialysis patients. PloS One. 2014;9: e93286 10.1371/journal.pone.0093286
    1. Marcelli D, Usvyat LA, Kotanko P, Bayh I, Canaud B, Etter M, et al. Body Composition and Survival in Dialysis Patients: Results from an International Cohort Study. Clin J Am Soc Nephrol CJASN. 2015; 10.2215/CJN.08550814
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40: 373–383.
    1. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol JASN. 1993;4: 1205–1213.
    1. Garred LJ, Barichello DL, Canaud BC, McCready WG. Simple equations for protein catabolic rate determination from pre dialysis and post dialysis blood urea nitrogen. ASAIO J Am Soc Artif Intern Organs 1992. 1995;41: 889–895.
    1. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol Bethesda Md 1985. 2000;89: 465–471. 10.1152/jappl.2000.89.2.465
    1. Terrier N, Jaussent I, Dupuy A-M, Morena M, Delcourt C, Chalabi L, et al. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc—Eur Ren Assoc. 2008;23: 345–353. 10.1093/ndt/gfm573
    1. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189: e15–62. 10.1164/rccm.201402-0373ST
    1. Carrero JJ, Johansen KL, Lindholm B, Stenvinkel P, Cuppari L, Avesani CM. Screening for muscle wasting and dysfunction in patients with chronic kidney disease. Kidney Int. 2016; 10.1016/j.kint.2016.02.025
    1. Hogrel J-Y, Payan CA, Ollivier G, Tanant V, Attarian S, Couillandre A, et al. Development of a French isometric strength normative database for adults using quantitative muscle testing. Arch Phys Med Rehabil. 2007;88: 1289–1297. 10.1016/j.apmr.2007.07.011
    1. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61: 1059–1064.
    1. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A physical activity questionnaire for the elderly. Med Sci Sports Exerc. 1991;23: 974–979.
    1. Anderton N, Giri A, Wei G, Marcus RL, Chen X, Bjordahl T, et al. Sedentary Behavior in Individuals With Diabetic Chronic Kidney Disease and Maintenance Hemodialysis. J Ren Nutr. 2015;25: 364–370. 10.1053/j.jrn.2015.01.018
    1. Cohen J. Statistical power analysis for the behavioral sciences Rev. ed. New York: Academic Press; 1977.
    1. Baumgartner RN, Ross R, Heymsfield SB. Does adipose tissue influence bioelectric impedance in obese men and women? J Appl Physiol Bethesda Md 1985. 1998;84: 257–262. 10.1152/jappl.1998.84.1.257
    1. Workeneh BT, Mitch WE. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr. 2010;91: 1128S–1132S. 10.3945/ajcn.2010.28608B
    1. Morishita Y, Kubo K, Haga Y, Miki A, Ishibashi K, Kusano E, et al. Skeletal muscle loss is negatively associated with single-pool Kt/V and dialysis duration in hemodialysis patients. Ther Apher Dial Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther. 2014;18: 612–617. 10.1111/1744-9987.12174
    1. Chertow GM, Owen WF, Lazarus JM, Lew NL, Lowrie EG. Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int. 1999;56: 1872–1878. 10.1046/j.1523-1755.1999.00734.x
    1. Zelle DM, Klaassen G, van Adrichem E, Bakker SJL, Corpeleijn E, Navis G. Physical inactivity: a risk factor and target for intervention in renal care. Nat Rev Nephrol. 2017;13: 152–168. 10.1038/nrneph.2016.187
    1. Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol CJASN. 2008;3: 348–354. 10.2215/CJN.02870707
    1. Chacon-Cabrera A, Lund-Palau H, Gea J, Barreiro E. Time-Course of Muscle Mass Loss, Damage, and Proteolysis in Gastrocnemius following Unloading and Reloading: Implications in Chronic Diseases. PloS One. 2016;11: e0164951 10.1371/journal.pone.0164951
    1. Watson EL, Greening NJ, Viana JL, Aulakh J, Bodicoat DH, Barratt J, et al. Progressive Resistance Exercise Training in CKD: A Feasibility Study. Am J Kidney Dis Off J Natl Kidney Found. 2015;66: 249–257. 10.1053/j.ajkd.2014.10.019
    1. Lewis MI, Fournier M, Wang H, Storer TW, Casaburi R, Cohen AH, et al. Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients. J Appl Physiol Bethesda Md 1985. 2012;112: 72–78. 10.1152/japplphysiol.00556.2011
    1. Yardimci B, Sumnu A, Kaya I, Gursu M, Aydin Z, Karadag S, et al. Is handgrip strength and key pinch measurement related with biochemical parameters of nutrition in peritoneal dialysis patients? Pak J Med Sci. 2015;31: 941–945. 10.12669/pjms.314.7595
    1. Powers SK, Kavazis AN, DeRuisseau KC. Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol. 2005;288: R337–344. 10.1152/ajpregu.00469.2004
    1. Agence de la biomédecine. RAPPORT ANNUEL 2015 Réseau Epidémiologie et Information en Néphrologie. 2015.
    1. Bohé J, Rennie MJ. Muscle protein metabolism during hemodialysis. J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found. 2006;16: 3–16. 10.1053/j.jrn.2005.07.005

Source: PubMed

3
Prenumerera